Where does Stan Froehner work?

Stan Froehner is CFO, Chairman, and Co-Founder of Myosana Therapeutics.

What companies did Stan Froehner found?

Stan Froehner founded Myosana Therapeutics.

Where did Stan Froehner go to school?

Stan Froehner studied at Harvard Medical School (Postdoctoral Research, Neurobiology and Neurosciences); Caltech (Doctor of Philosophy (PhD), Biochemistry and Neurophysiology); The University of Texas at Austin (Bachelor of Science (BS), Chemistry).

Stan Froehner

Founder

CFO, Chairman, and Co-Founder at Myosana Therapeutics

Seattle, Washington, United States

FoundedMyosana Therapeutics

Find your path to Stan

83 people in our graph share verified history with Stan — schools, employers, funds. One of them is your warm intro.

AndrewunlockedStan: together at UW Medicine (2008–2020)

Stan: together at Harvard Medical School

×3Stan: together at University of Washington

Stan: together at University of North Carolina at Chapel Hill

About

Stan Froehner is Co-Founder and Chairman of the Board of Myosana Therapeutics, Inc., a company developing non-viral gene therapies for Duchenne muscular dystrophy (DMD). The company's proprietary platform is designed to deliver genes of varying sizes to skeletal and cardiac muscle, including full-length dystrophin for individuals with DMD.

CFO, Chairman, and Co-Founder at Myosana Therapeutics

Co-founders at Myosana Therapeutics

Nick WhiteheadCEO, CSO & Co-Founder

Experience

Myosana Therapeutics, IncCo-Founder and Chairman of the Boardcurrent2018 — presentSeattle, Washington, United States
University of WashingtonUW Medicine Distinguished Professorcurrent2019 — presentGreater Seattle Area
UW MedicineProfessor and Chair2000 — 2020University of Washington School of Medicine
University of North Carolina at Chapel HillProfessor and Chair1992 — 2000
Dartmouth Medical SchoolProfessor of Biochemistry1978 — 1991

Skills & more

Molecular Biology9Grant Writing1Biochemistry5Neuroscience2Medical Education1Cell Biology6Lifesciences1Research1Program EvaluationScience2Genetics1Cell1

+6 more

Fluorescence MicroscopyCell CultureHigher EducationLife SciencesWestern BlottingImmunohistochemistry

From Stan's professional profile.

Frequently asked questions

Who is Stan Froehner?: Stan Froehner is Co-Founder and Chairman of the Board of Myosana Therapeutics, Inc., a company developing non-viral gene therapies for Duchenne muscular dystrophy (DMD). The company's proprietary platform is designed to deliver genes of varying sizes to skeletal and cardiac muscle, including full-length dystrophin for individuals with DMD.
Where does Stan Froehner work?: Stan Froehner is CFO, Chairman, and Co-Founder of Myosana Therapeutics.
What companies did Stan Froehner found?: Stan Froehner founded Myosana Therapeutics.
Where did Stan Froehner go to school?: Stan Froehner studied at Harvard Medical School (Postdoctoral Research, Neurobiology and Neurosciences); Caltech (Doctor of Philosophy (PhD), Biochemistry and Neurophysiology); The University of Texas at Austin (Bachelor of Science (BS), Chemistry).

Founder mafias

The University of Texas at Austin mafia318

Also came through, then founded or led a company.

Michael DellFounded Force10 Philip KrimMinorFounded Electron X +2 Michael GortonPhysics & Engineering w minor in EnglishFounded Principal Solar +2 Mike McNeilComputer ScienceFounded Fleet Device Management Inc. +2 Michael RoyzenBachelor of Science - BSFounded Smartlens +2 Amar SawhneyM.S. and PhDFounded Access Closure +2

+ 311 more

Caltech mafia153

Also came through, then founded or led a company.

Dario AmodeiProgress towards BSFounded Anthropic Fei-Fei LiDoctor of Philosophy - PhDFounded World Labs Bill GrossBachelor of Science (B.S.)Founded X1 +5 Chris VoigtPhDFounded Asimov +2 Gil ElbazBSFounded TenOneTen Ventures +1 Aditya RajagopalBachelor of Science (BS)Founded Esperto Medical +1

+ 146 more

Harvard Medical School mafia111

Also came through, then founded or led a company.

George ChurchFounded Editas Medicine +5 Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3 Andrey ZarurClinical ImmunologyFounded GreenLight Pandemic Response +3 Howard ChangM.D.Founded Accent Therapeutics +3 Michael TolentinoResidencyFounded Aviceda Therapeutics +2 Venky SoundararajanResearch Fellowship in GeneticsFounded nference +2

+ 104 more

Same school

Also attended Harvard Medical School262

Niko BonatsosFounder and Managing Partner of Verdict Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 256 more

Also attended Caltech247

Shaun MaguirePartner at Sequoia Capital Dario AmodeiCo-founder & CEO of Anthropic Fei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at Stanford Scott BillerInvestor at GV (Google Ventures)Seth LieblichInvestment Team at 8VC Susannah BarbeeVice President, Translational Immunology at Deerfield Management Company

+ 241 more

Also attended The University of Texas at Austin738

Michael DellFounder & CEO of Dell Technologies Viswa SankaranarayananVenture Partner at Monta Vista Capital Todd KleinManaging Partner, Revolution Growth at Revolution Sapna MehtaInvestor at Revolution Anish AggarwalInvestor at Lightbank Andrew ScottSenior Finance Manager at Greycroft

+ 732 more

Shared employers

Also worked at University of Washington182

Mike FridgenVenture Partner at Madrona Venture Group Sid ShenaiVenture partner at Madrona and co-founder and CEO of Proof Diagnostics Paul JennyBoard Chair at CincyTech Jason PrestonInvestor at Alsop Louie Partners Elliot HershbergScientist, Writer, and Investor on a mission to accelerate The Century of Biology Luke RigganAssociate at Amplify Partners

+ 176 more

Also worked at UW Medicine6

AndrewAdvisor at Clear Ventures Peter van OppenManaging Director at Trilogy Equity Partners Harris RosePartner at CIVC Ben ZanielloAdvisor at Allumia Ventures Derek DiRoccoPartner at RA Capital Ashley Abel, Ph.D.Founder at First-in-class therapeutics for endometriosis

Also worked at University of North Carolina at Chapel Hill63

Stefan SchroppSenior Regulatory Counsel at Paradigm Ashley N. PattonSr. Stewardship Analyst at Sands Capital Ventures Lucy LiuPrincipal at Longwood Fund Haley LeversedgeInvestor at Silversmith Capital Partners Chris HartshornAdvisor at Chrysalix William Tunstall-PedoeBritish entrepreneur focused on Artificial Intelligence and Deep Tech

+ 57 more

Also worked at Dartmouth Medical School14

Charles BeyrouthyFounder & Managing Partner at Forma Prime Ryan GreeneMedical Director at Seaside Ventures Russ RapaportAssociate at 1315 Capital Basile MontagneseAssociate at Ajax Health Shayan BhattacharyyaVenture Partner at Zoic Capital Dr. Hannah GalvinAdvisor at Reach Capital

+ 8 more